Navigation Links
KAIST developed the biotemplated design of piezoelectric energy harvesting device
Date:12/3/2013

A research team led by Professor Keon Jae Lee and Professor Yoon Sung Nam from the Department of Materials Science and Engineering at KAIST has developed the biotemplated design of flexible piezoelectric energy harvesting device, called "nanogenerator."

Nature has its own capabilities to spontaneously synthesize and self-assemble universal materials with sophisticated architectures such as shells, sea sponges, and bone minerals. For instance, the natural sea shell, consisting of calcium carbonate (CaCO3), is very rigid and tough whereas the artificial chalk made by the same material is fragile. In addition, most of artificial syntheses are performed under toxic, expensive and extreme environments in contrast to the natural syntheses, which are processed in benign and mild surroundings. If human can mimic these biological abilities, a variety of ecological and material issues can be solved.

The KAIST team modified a M13 viral gene, which is harmless to human and widely exist in nature, to utilize its remarkable ability of synthesizing a highly piezoelectric inorganic material, barium titanate (BaTiO3). By using this biotemplated piezoelectric material, a high-output flexible nanogenerator could be fabricated with an enhanced performance. The flexible piezoelectric nanogenerator that converts mechanical energy of tiny movements into electrical energy is an attractive candidate for the next generation energy harvesting technology. This biotemplated nanogenerator will drive commercial LCD screens and LED bulbs by simple finger movements.

Professor Lee said, "This is the first time to introduce a biotemplated inorganic piezoelectric material to a self-powered energy harvesting system, which can be realized through eco-friendly and efficient material syntheses."


'/>"/>

Contact: Lan Yoon
hlyoon@kaist.ac.kr
82-423-502-294
The Korea Advanced Institute of Science and Technology (KAIST)
Source:Eurekalert  

Page: 1

Related biology news :

1. Launched the Saudi Aramco-KAIST CO2 Management Center in Korea
2. KAIST and Saudi Aramco agreed to establish a joint CO2 research center in Korea
3. New tool developed for profiling critical regulatory structures of RNA molecules
4. NREL developed mobile app for alternative fueling station locations released
5. New protocol developed to decontaminate human fetal tissues used for cell transplantation
6. Low-cost in-vitro fertilization method developed at CU may help couples in developing countries
7. Newly developed medium may be useful for human health, biofuel production, more
8. Maps developed to help forest industry outwit climate change
9. Rotavirus vaccine developed in India demonstrates strong efficacy
10. New monoclonal antibody developed that can target proteins inside cancer cells
11. Flu breakthrough: New drug developed to combat flu pandemic
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
KAIST developed the biotemplated design of piezoelectric energy harvesting device
(Date:1/31/2017)...  Spero Therapeutics, LLC, a biopharmaceutical company founded ... bacterial infections, today announced it has acquired a ... Bono Bio Ltd (PBB) to bolster its pipeline ... of Gram-negative bacteria.   The assets acquired have been ... group company. "The acquisition of these ...
(Date:1/25/2017)... , Jan. 25, 2017 The Elements of ... (IAM) lifecycle is comprised of a comprehensive set ... purpose of maintaining digital identities and providing a ... applications. There are significant number of programs opted ... to time by optimizing processes and changing policies. ...
(Date:1/21/2017)... , Jan 20, 2017 Research and Markets ... Market 2017-2021" report to their offering. ... The global voice recognition biometrics market ... The report covers the present scenario and the ... To calculate the market size, the report considers the revenue generated ...
Breaking Biology News(10 mins):
(Date:2/28/2017)... ... February 28, 2017 , ... ... antibody therapeutics from millions-diverse immune repertoires, today announced a strategic partnership with ... genetically engineered to express human antibodies. The partnership will use GigaGen technology to ...
(Date:2/28/2017)... 2017  ITL Limited ( ASX:ITD ), an ... partner that provides innovative products and solutions to ... announces its rebrand to ITL Health Group (ITL). ... of the Company,s unified global rebranding plan and ... corporate website, ITLHealthGroup.com . ITL,s new brand ...
(Date:2/28/2017)... and NEW YORK , February 28, ... Application accepted by the FDA for avelumab  Prognosis ... has metastasized   EMD ... Germany , in the US and Canada ... Food and Drug Administration (FDA) has accepted for Priority Review ...
(Date:2/27/2017)... A Europe-wide survey of institutes conducted by the Basel Declaration ... treat them with due care. The survey polled a total of ... indicates that there is a strong commitment among animal researchers across ... of the 3Rs (Refine, Reduce, Replace)  ... What are the 3Rs? Refine: ...
Breaking Biology Technology: